Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia

N/ACompletedNCT01940198

Holdsworth House Medical Practice117 enrolled

Overview

This observational study will aim to determine long-term atazanavir experience in a high HIV caseload primary care practice in Sydney, Australia.

This observational study will aim to determine long term atazanavir experience in HIV-1 infected patients in a primary care setting. 3\. OBJECTIVES OF THE STUDY i. Primary objective Long-term (2 years or greater) atazanavir experience in HIV-1 infected patients in a primary care setting through retrospective data collection. ii. Secondary objectives 1. To illustrate long term therapeutic efficacy of atazanavir in ART naïve and experienced HIV-1 infected patients. 2. To illustrate long term tolerability to atazanavir in ART naïve and experienced HIV-1 infected patients. 3. To identify ART treatment history in ART naïve and experienced HIV-1 infected patients on ATV. 4. To identify contraindicated therapy in ART naïve and experienced HIV-1 infected patients on ATV.

Study Type

OBSERVATIONAL

Enrollment

117

Conditions

HIV

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: 1. HIV-1 positive 2. Have commenced ATV between 2002-2008 (Baseline) 3. Follow-up data (clinical and laboratory) available from baseline Exclusion Criteria: 1. Patients not commenced ATV between 2002-2008 2. No follow-up data (clinical and laboratory) available from baseline 3. Patient 'lost to follow-up' with \< 2 years of follow-up data (Clinical and laboratory)

Locations (1)

Holdsworth House Medical Practice

Sydney, New South Wales, Australia